Skip to main content
SpringerLink
Log in

High formulary inclusion for rivaroxaban and ticagrelor

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

High formulary inclusion for rivaroxaban and ticagrelor. Pharmacoecon. Outcomes News 651, 11 (2012). https://doi.org/10.2165/00151234-201206510-00033

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-201206510-00033

Keywords

Search

Navigation